115 related articles for article (PubMed ID: 1838069)
1. Basal and stimulated plasma atrial natriuretic factor in patients with type 1 diabetes with and without nephropathy.
McKnight JA; Roberts G; Sheridan B; Bell PM; Atkinson AB
Diabet Med; 1991 Oct; 8(8):765-9. PubMed ID: 1838069
[TBL] [Abstract][Full Text] [Related]
2. Atrial natriuretic factor in various stages of diabetic nephropathy.
Sawicki PT; Heinemann L; Rave K; Hohmann A; Berger M
J Diabet Complications; 1988; 2(4):207-9. PubMed ID: 2976764
[TBL] [Abstract][Full Text] [Related]
3. Basal and stimulated plasma atrial natriuretic factor in type 2 diabetes.
McKnight JA; Sheridan B; Roberts G; Atkinson AB
Diabetes Res; 1991 Nov; 18(3):143-8. PubMed ID: 1841825
[TBL] [Abstract][Full Text] [Related]
4. Human atrial natriuretic peptide in patients with type 1 diabetes mellitus: is it related to the development of diabetic nephropathy?
Jungmann E; Felber A; Graeber S; Hillmann U; Haak T; Palitzsch KD; Usadel KH
Clin Investig; 1993 Aug; 71(8):604-9. PubMed ID: 8219653
[TBL] [Abstract][Full Text] [Related]
5. Significant natriuretic and antihypertensive action of the epithelial sodium channel blocker amiloride in diabetic patients with and without nephropathy.
Andersen H; Hansen PB; Bistrup C; Nielsen F; Henriksen JE; Jensen BL
J Hypertens; 2016 Aug; 34(8):1621-9. PubMed ID: 27214087
[TBL] [Abstract][Full Text] [Related]
6. [Atrial natriuretic factor in patients with type 1 diabetes mellitus in various stages of diabetic nephropathy].
Sawicki P; Heinemann L; Rave K; Berger M
Z Kardiol; 1988; 77 Suppl 2():111-3. PubMed ID: 2970165
[TBL] [Abstract][Full Text] [Related]
7. Effects of dietary sodium on blood pressure in IDDM patients with nephropathy.
Mühlhauser I; Prange K; Sawicki PT; Bender R; Dworschak A; Schaden W; Berger M
Diabetologia; 1996 Feb; 39(2):212-9. PubMed ID: 8635674
[TBL] [Abstract][Full Text] [Related]
8. Short-term treatment with ramipril normalizes renal haemodynamics and the natriuretic response to a sodium load in type 1 diabetic patients with early nephropathy.
Stenvinkel P; Bolinder J; Alvestrand A
Acta Diabetol; 1997 Mar; 34(1):10-7. PubMed ID: 9134051
[TBL] [Abstract][Full Text] [Related]
9. Basal and saline-stimulated plasma atrial natriuretic hormone in Cushing's syndrome.
McKnight JA; McCance DR; Roberts G; Sheridan B; Atkinson AB
Acta Endocrinol (Copenh); 1991 Jan; 124(1):7-11. PubMed ID: 1825738
[TBL] [Abstract][Full Text] [Related]
10. On the pathogenesis of arterial blood pressure elevation early in the course of diabetic nephropathy.
Hommel E; Mathiesen ER; Giese J; Nielsen MD; Schütten HJ; Parving HH
Scand J Clin Lab Invest; 1989 Oct; 49(6):537-44. PubMed ID: 2531916
[TBL] [Abstract][Full Text] [Related]
11. Abnormal albuminuria and blood pressure rise in incipient diabetic nephropathy induced by exercise.
Christensen CK
Kidney Int; 1984 May; 25(5):819-23. PubMed ID: 6471668
[TBL] [Abstract][Full Text] [Related]
12. Atrial natriuretic factor in hypertensive and normotensive diabetic patients.
Ferri C; Piccoli A; Laurenti O; Bellini C; De Mattia G; Santucci A; Balsano F
Diabetes Care; 1994 Mar; 17(3):195-200. PubMed ID: 8174447
[TBL] [Abstract][Full Text] [Related]
13. Impaired intrarenal dopamine production following intravenous sodium chloride infusion in type 1 (insulin-dependent) diabetes mellitus.
Stenvinkel P; Saggar-Malik AK; Wahrenberg H; Diczfalusy U; Bolinder J; Alvestrand A
Diabetologia; 1991 Feb; 34(2):114-8. PubMed ID: 1829692
[TBL] [Abstract][Full Text] [Related]
14. Elevated vascular endothelial growth factor in type 1 diabetic patients with diabetic nephropathy.
Hovind P; Tarnow L; Oestergaard PB; Parving HH
Kidney Int Suppl; 2000 Apr; 75():S56-61. PubMed ID: 10828763
[TBL] [Abstract][Full Text] [Related]
15. Increased secretion of TGF-beta1 by peripheral blood mononuclear cells from patients with Type 1 diabetes mellitus with diabetic nephropathy.
Korpinen E; Groop PH; Fagerudd JA; Teppo AM; Akerblom HK; Vaarala O
Diabet Med; 2001 Feb; 18(2):121-5. PubMed ID: 11251675
[TBL] [Abstract][Full Text] [Related]
16. Atrial natriuretic peptide and response to changing plasma volume in diabetic nephropathy.
Lieberman JS; Parra L; Newton L; Scandling JD; Loon N; Myers BD
Diabetes; 1991 Jul; 40(7):893-901. PubMed ID: 1647996
[TBL] [Abstract][Full Text] [Related]
17. [The role of human atrial natriuretic peptide on pathogenesis of nephropathy in patients with type I diabetes mellitus].
Jungmann E; Graeber S; Scherberich J; Usadel KH
Med Klin (Munich); 1992 Dec; 87(12):622-5. PubMed ID: 1287423
[TBL] [Abstract][Full Text] [Related]
18. Elevated plasma atrial natriuretic peptide level in the early phase of microalbuminuria in patients with non-insulin-dependent diabetes mellitus.
Shinoda T; Ishihara M; Kurimoto F; Aizawa T; Hiramatsu K; Shirota T; Takasu N; Yamada T
Clin Nephrol; 1990 Nov; 34(5):202-7. PubMed ID: 2148510
[TBL] [Abstract][Full Text] [Related]
19. Pronatriodilatin gene polymorphisms, microvascular permeability, and diabetic nephropathy in type 1 diabetes mellitus.
Nannipieri M; Penno G; Pucci L; Colhoun H; Motti C; Bertacca A; Rizzo L; De Giorgio L; Zerbini G; Mangili R; Navalesi R
J Am Soc Nephrol; 1999 Jul; 10(7):1530-41. PubMed ID: 10405209
[TBL] [Abstract][Full Text] [Related]
20. Increased prevalence of salt sensitivity of blood pressure in IDDM with and without microalbuminuria.
Strojek K; Grzeszczak W; Lacka B; Gorska J; Keller CK; Ritz E
Diabetologia; 1995 Dec; 38(12):1443-8. PubMed ID: 8786018
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
